1 – Dec |
6:00 – 8:00 PM |
Registration |
6:30 – 8:00 PM |
Welcome Reception |
|
|
|
2 – Dec |
7:00 AM – 7:00 PM |
Registration |
7:00 – 8:00 AM |
Breakfast featuring Therapeutic Affinity Roundtables |
8:00 – 9:00 AM |
Plenary Session: Partnering for Cures: Paving the Way to Cross-Sector Collaborations |
9:15 – 11:40 AM |
Partnering |
9:15 – 10:10 AM Breakout Sessions |
Crossing the Valley of Death: The Translational Funding and Management Gap Maximizing Your ROP (Return on Philanthropy) Cure Entrepreneurs: New Nonprofit Business Models to Accelerate Research |
10:15 – 11:40 AM |
Medical Research Foundation Presentations |
10:15 – 10:40 AM |
Multiple Myeloma Research Foundation Louise M. Perkins, Ph.D., Chief Scientific Officer Alzheimer's Drug Discovery Foundation Howard Fillit, M.D., Executive Director Foundation Fighting Blindness Stephen Rose, Ph.D., Chief Research Officer |
10:45 – 11:10 AM |
Leukemia & Lymphoma Society Louis J. DeGennaro, Ph.D., Executive VP and Chief Scientific Officer Alzheimer's Association Harry Johns, President and CEO Hide & Seek Foundation Jonathan Jacoby, CEO, The R.A.R.E. Project; Chair, The Hide & Seek Foundation for Lysosomal Disease Research Steven U. Walkley, DVM, Ph.D., Sidney Weisner Laboratory of Genetic Neurological Disease, Department of Neuroscience, Rose F. Kennedy Center, Albert Einstein College of Medicine; Investigator, SOAR-NPC Project |
11:15 – 11:40 AM |
Melanoma Research Alliance Suzanne Topalian, M.D., Chief Science Officer Michael J. Fox Foundation for Parkinson's Research Sohini Chowdhury, Associate Director, Team Leader International Mental Health Research Organization Eric J. Nestler, M.D., Ph,D., Scientific Advisory Board Chairman |
|
12:00 – 1:30 PM |
Luncheon Plenary: A Conversation between Michael Milken and Jeffrey Kindler |
1:45 – 3:40 PM |
Medical Research Foundation Presentations |
1:45 – 2:10 PM |
Addario Lung Cancer Medical Institute Steve Young, President ALS Therapy Development Institute Steve Perrin, Ph.D., CEO & Chief Scientific Officer PATH Malaria Vaccine Initiative Christian Loucq, M.D., Director |
2:15 – 2:40 PM |
Children's Tumor Foundation Kim Hunter-Schaedle, Ph.D., Chief Scientific Officer John W. Risner, President Fast Forward Kathy Smith, Managing Director Medicines for Malaria Venture Patrick Nef, Ph.D., Executive VP of Business Development |
2:45 – 3:10 PM |
Dr. Susan Love Research Foundation Susan Love, M.D., President Accelerated Cure Project for MS Hollie Schmidt, M.S., VP of Scientific Operations Global Alliance for TB Drug Development Asmita Barve, M.A., M.B.A., Manager, Resource Mobilization |
3:15 – 3:40 PM |
Susan G. Komen for the Cure Elizabeth Thompson, Vice President, Health Sciences Myelin Repair Foundation Russell “Rusty” Bromley, COO Aeras Global TB Vaccine Foundation Lewellys F. Barker, M.D., MPH, Senior Medical Advisor |
|
1:45 – 4:40 PM |
Partnering |
3:45 – 4:40 PM Breakout Sessions |
Partnering with Patients Giving Smarter: Building a High-Impact Philanthropic Portfolio Venture Philanthropy: The New Venture Capital? (Audio clip online)
|
5:00 PM – 6:30 PM |
Networking Reception |
|
|
|
3 – Dec |
7:00 AM – 3:00 PM |
Registration |
7:00 – 8:00 AM |
Breakfast featuring Therapeutic Affinity Roundtables |
8:00 – 9:00 AM |
Plenary Session: Breakthrough Science |
9:15 – 11:40 AM |
Partnering |
9:15 – 10:10 AM Breakout Sessions |
Industry's Changing Business Models Stories from the Front Lines of Philanthropy Is NIH Investing in Innovation? |
10:15 – 11:40 AM |
Medical Research Foundation Presentations |
10:15 – 10:40 PM |
Pancreatic Cancer Action Network Julie Fleshman, President and CEO MDA Venture Philanthropy Jane Larkindale, Ph.D., Portfolio Director International AIDS Vaccine Initiative Seth Berkley, M.D., President, CEO and Founder |
10:45 – 11:10 AM |
Mesothelioma Applied Research Foundation Christopher Hahn, Executive Director Parent Project Muscular Dystrophy Pat Furlong, Founding President and CEO Drugs for Neglected Diseases initiative Jana Armstrong, Executive Director, DNDi North America |
11:15 – 11:40 AM |
Prostate Cancer Foundation Jonathan Simons, M.D., President and CEO Rett Syndrome Research Trust Monica Coenraads, Executive Director Institute for OneWorld Health Robert Farrell, Chief Financial Officer |
|
12:00 – 1:30 PM |
Luncheon Plenary: A Conversation between Michael Milken, Gail Cassell, and Joshua Sharfstein |
1:45 – 3:40 PM |
Medical Research Foundation Presentations |
1:45 – 2:10 PM |
Chordoma Foundation Simone Sommer, M.D., MPH, Cofounder, Visionary and President Josh Sommer, Cofounder, Research Coordinator, Echoing Green Social Entrepreneur Fellow Epilepsy Therapy Project Joyce A. Cramer, President Seattle Biomedical Research Institute Ken Stuart, President and Director |
2:15 – 2:40 PM |
Life Raft Group Norman Scherzer, Executive Director Progeria Research Foundation Audrey Gordon, President and Executive Director Partnership for Cures Bruce E. Bloom, Ph.D., President and Chief Science Officer |
2:45 – 3:10 PM |
Damon Runyon Cancer Research Foundation Lorraine W. Egan, Executive Director Tuberous Sclerosis Alliance Vicky Holets Whittemore, Ph.D, VP and Chief Scientific Officer Creative Commons John WIlbanks, Vice President, Science Commons |
3:15 – 3:40 PM |
Alpha-1 Foundation John W. Walsh, Co-founder, President and CEO Juvenile Diabetes Research Foundation Alan J. Lewis, Ph.D., President and CEO Biomarkers Consortium, Foundation for the NIH David Wholley, Director, Director, The Biomarkers Consortium Foundation for the National Institutes of Health Shawnmarie Mayrand-Chung, Ph.D., J.D., NIH Program Director, The Biomarkers Consortium and Senior Advisor to The Biomarkers Consortium National Institutes of Health, Public-Private Partnerships Program |
|
1:45 – 4:40 PM |
Partnering |
3:45 – 4:40 PM Breakout Sessions |
Challenges of Clinical Trials and Product Approval Collaboration Models in Global Health Patients 2.0 |